Switch to:
More From Other Websites
Steve Mandel Exits Position in Williams Companies in 1st Quarter Jun 24 2016
British Banks Top Friday’s 52-Week Low Club Jun 24 2016
This Merger Could Mean Returns Of Up To 40% Jun 24 2016
Valeant Gets Credit Downgrade As Recovery Slower Than Hoped Jun 23 2016
Valeant Returns in Thursday’s 52-Week Low Club Jun 23 2016
ETF’s with exposure to Valeant Pharmaceuticals International, Inc. : June 23, 2016 Jun 23 2016
Valeant Pharmaceuticals: Now You Downgrade It? Jun 23 2016
Forget a 'Flash Crash'; How About a 'Flash Squeeze' Instead? Jun 23 2016
Valeant Pharmaceuticals (VRX) Stock Rating Downgraded at JPMorgan Jun 23 2016
Tesla, SolarCity and the Race to the Bottom Jun 23 2016
Valeant Pharma downgraded by JP Morgan Jun 23 2016
New Valeant Accounting Chief is Early Step in Overhaul Jun 22 2016
Valeant Enlists Former Tyco Exec for More Help With Accounting Jun 22 2016
Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q1, 2016 By the Numbers :... Jun 22 2016
Research Report Initiated on Select Healthcare Equities Jun 22 2016
CFO Moves: Taro Pharmaceutical, Valeant Jun 22 2016
What Do Analysts Think about Valeant? Jun 22 2016
Valeant Pharma names Eldessouky accounting chief Jun 21 2016
Bill Ackman Is Gearing Up for Another Campaign Against Herbalife Jun 21 2016
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal... Jun 21 2016
Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations Jun 17 2016
Valeant Pharmaceuticals Announces Launch Of New PreserVision® AREDS 2 Formula + Multivitamin Jun 16 2016
Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director Jun 15 2016
LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment Jun 10 2016
Valeant To Participate In FDA Advisory Committee Meeting On July 19 Jun 09 2016
Valeant loses money in 1Q, cuts outlook, shares plunge Jun 07 2016
Valeant Pharmaceuticals To Webcast 2016 Annual Meeting Of Shareholders Jun 07 2016
Valeant shares plunge after it slashes profit forecast Jun 07 2016
Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results Jun 07 2016
Business Highlights Jun 03 2016
Valeant defaults on some of its debt Jun 03 2016
Valeant Pharmaceuticals Receives Additional Notice Of Default Under Indentures Due To Delayed Form... Jun 03 2016
Valeant Pharmaceuticals To Present Six Abstracts At 2016 ASCO Annual Meeting Jun 01 2016
Valeant Pharmaceuticals To Hold Conference Call On June 7, 2016 May 31 2016
Valeant rejected joint takeover bid from Takeda, TPG in spring - source May 26 2016
Valeant appoints Tyco's Sam Eldessouky corporate controller May 26 2016
Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller May 26 2016
Valeant CEO Papa plans to lower debt by more than $1.5 billion in 2016 May 23 2016
Bausch + Lomb Wins Walmart "Supplier of the Year" Award May 23 2016
Valeant Pharmaceuticals Receives Notice Of Default From Bondholders May 19 2016
Valeant Pharmaceuticals To Participate At The UBS Global Healthcare Conference May 18 2016
Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters May 16 2016
Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel May 16 2016
Valeant Pharma promises to do better with deadlines May 09 2016
Valeant Pharmaceuticals Announces Expected Timing Of Form 10-Q Filing And Reiterates 2016 First... May 09 2016
Valeant Pharmaceuticals Announces Patient Access And Pricing Committee To Oversee Pricing Of Drugs May 05 2016
Valeant Pharmaceuticals Announces Collaboration Between Bausch + Lomb And IBM May 05 2016
Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals May 03 2016
Warren Buffett says more likely to buy IBM shares than sell - CNBC May 02 2016
Warren Buffett says more likely to buy IBM shares than sell - CNBC May 02 2016
Buffett says drugmaker Valeant had flawed business model May 02 2016
Valeant files overdue financial report, ending debt default Apr 29 2016
Valeant files overdue financials, averts debt default Apr 29 2016
Valeant Announces Nominees For Election To Board Of Directors Apr 29 2016
Lawmakers blast Valeant for price-gouging tactics Apr 27 2016
Business Highlights Apr 27 2016
Senate hearing into Valeant includes top hedge fund investor Apr 26 2016
Valeant Pharma picks Perrigo leader to become next CEO Apr 25 2016
Report: Valeant finalizing contract with Perrigo's CEO Apr 22 2016
US open: Stocks decline as investors digest data Apr 15 2016
Exclusive: Valeant calls in investment banks to weigh options - sources Apr 14 2016
Valeant CEO agrees to be deposed in Senate drug price probe Apr 13 2016
Business Highlights Apr 11 2016
Valeant has told outgoing CEO to cooperate with Senate Apr 11 2016
US stocks near flat ahead of Yellen speech, jobs data Mar 28 2016
US STOCKS-Wall St ends flat as recent rally spurs caution Mar 21 2016
Valeant CEO Pearson to exit, Ackman to join board Mar 21 2016
US STOCKS-Wall St flat as Fed still dominates investor sentiment Mar 21 2016
S&P says it may cut Ackman hedge fund's rating Mar 17 2016
US STOCKS-Wall St dips as healthcare lags before Fed statement Mar 15 2016
Valeant shares plunge 49% on default warning, outlook Mar 15 2016
US STOCKS-Health, materials shares drag on Wall St in lull before Fed news Mar 15 2016
Valeant shares plunge 45% on revised forecasts Mar 15 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK